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1. Introduction
  Leishmaniasis is an important tropical vector-borne 
infectious disease. There are two common forms of 
leishmaniasis, cutaneous and visceral presentations. 
Visceral leishmaniases (VL), with spreading epidemics 
in India and Africa, and some sporadic cases in 
Mediterranean countries, reveal various clinical and 
public health characteristics depending on the geographic 
underlyings[1-4]. VL is considered an important tropical 
blood infection. Palumbo et al noted that “Leishmaniasis 
is distributed worldwide and 13 million people are 
estimated to be infected, with about 1.8 million new cases 
each year[3]”. Hence, it is no doubt on the public health 
importance of this parasitic infection. WHO accepted for the 
public health importance of this infection and proposed for 
these strategies (a) training program on diagnosis and case 
management of leishmaniasis; (b) setting up a harmonized 
regional surveillance system; (c) creating a connecting 
network of experts and (d) promoting international 
commitment of disease management[4].
  Although Thailand has high prevalence of vector-borne 
diseases malaria and dengue fever, the VL is a non endemic 
infectious disease and seldom mentioned in the literature. 
The first Thai case report of leishmaniasis infection was 
documented in the literature in 1981 by Puavilai et al[5]. 
After the first report, there have been many sporadic case 
reports of leishmaniasis in Thailand. However, most cases 
are cutaneous leishmaniasis. Nevertheless, the serious 
form of leishmaniasis can be detectable in Thailand. The 
infected cases seem to be the serious concern in the disease 
control since there has never been the vector of leishmanial 
parasite in Thailand and the existence of the disease 
seems to be the new emerging infectious disease and the 
root cause analysis has to be performed. The existence of 
the leishmaniasis in Thailand is an interesting situation. 
Indeed, the infection should not be existed due to two main 
reasons (a) there is no vector and (b) there is no pathogen. 
However, the disease finally occurred and this implies the 
importance of traveling medicine at present.
  The general situation of the leishmaniasis in Thailand is 
hereby reviewed. Although Thailand is a tropical country, 
the leishmaniasis is not endemic but sporadic. The 
serious form of leishmaniasis, the visceral leishmaniasis 
is also detectable in Thailand. Here, the author performed 
a literature review of the reports of bone marrow 
leishmaniasis in Thailand and present the summation as a 
review. The main aim is to summarize the characteristics 
of this infection among Thai patients for further referencing 
database.
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2. Retrospective review
  Here, the author performed an in depth literature review 
of the reports of bone marrow leishmaniasis, a specific kind 
of visceral leishmaniasis, in Thailand in order to summarize 
the characteristics of this infection among Thai patients. 
Adding to the previous known knowledge[2], an updating 
literature review of the papers concerning bone marrow 
leishmaniasis in Thailand was done. The two international 
database of published works, Index Medicus and Science 
Citation Index were using in searching of documents. 
Additionally, the author also reviewed the published works 
in all 256 local Thai journals, which are not included in the 
international citation index but available in local searching 
engine namely Thai Index Medicus. The literature review 
focused on the years 1981-2011. The key word for searching 
is “lesimaniasis” and “Thailand”. According to review, 
there were 24 reports on lesihmaniasis but only 5 reports 
were dealing with bone marrow leishmaniasis and were 
further recruited for further study. The details of clinical 
presentations of the patients (such as demographical data; 
sex and age, clinical manifestation, diagnosis, treatment, 
and discharge status) of all indexed cases in all included 
reports were studied. Descriptive statistics using SPSS 7.0 for 
Windows were used in analyzing the patient characteristics.
There have been at least 5 reports[7-9] in the literature of 6 
cases (5 males and 1 female) of bone marrow leishmaniasis 
in the Thai population without any death case. Average 
age of the indexed cases is 25.6依17.1 years old. All except 
1 cases are immunocompetent (there is 1 Anti HIV 
seropositive case). Concerning the clinical manifestation 
and physical examination, all had hepatosplenomegaly 
and all except two cases had prolonged increased body 
temperature. At the time of diagnosis, there was no 
detectable leishmanial parasite in examined peripheral 
blood smear however anemia and thrombocytopenia could 
be seen in all cases (pancytopenia can be seen in 5 cases). 
The bone marrow study shoed revealed increased bone 
marrow cellularity, adequate production of magakaryocytes, 
erythroid and myeloid precursors with the important 
findings “active hemophagocytosis with increased 
proliferation of lymphoidplasma cell line in the bone 
marrow with detected amastigotes of Leishmania donovani.” 
Considering the treatment, pantavalent antimony compound 
was prescribed for all except 1 indexed cases (the left 
case was treated by amphotericin B[10]) and the excellent 
improvement and complete recovery of the clinical and 
hematologic abnormalities were observed promptly after the 
administration.
3. Discussion
  Leishmanioses are a group of parasitic infections that 
affect human beings and other mammals. They are caused 
by different species of trypanosomatids of the genus 
Leishmania[11-12]. The distribution of this specific infectious 
disease, which is found throughout the world, is determined 
by various factors linked to both human activity as well 
as climatic change. The heteroecious life cycle of the 
Leishmania is mentioned. It includes an invertebrate host, 
the specific sandflies in the Phlebotomidae family. The 
dog is also a main reservoir host and it can present both 
cutaneous and visceral clinical signs[12].
  Considering VL, the typical symptomatic triad, anemia-
fever-enlarged spleen, may be not completely fulfilled in 
all cases. The diagnosis of visceral form is generally derived 
by the demonstration of amastigotes of the leishmanial 
parasite(s) in the aspirated fluid from the bone marrow, 
the spleen, and rarely from the lymph nodes, or the 
liver[13]. Berentsen et al said that the identification of the 
parasites in bone marrow biopsy should be performed in all 
pancytopenic patients with fevers of unknown origin and 
had the previous history of visiting to the Mediterranean, the 
endemic area of VL[13]. In Thailand, it can be seen that all 
bone marrow leishmaniasis cases had the history of visiting 
to the Middle East for working as labors[2]. All had the 
classical triads but negative smear[2]. Indeed, in Thailand, 
many other tropical infectious diseases such as malaria and 
dengue can result in the mentioned triad characteristics as 
well. However, the bone marrow aspiration to find the cause 
of unexplained pancytopenia can be the final tool that brings 
the final confirmations of infections in all cases[2,14].
  In this series, the bone marrow appearance is concordant 
with the classical findings according to the bone marrow 
leishmaniasis definition[2]. Detection of amastigote is 
the key point of diagnosis[2]. However, rare appearances 
such as myelofibrosis could be observed[15]. Concerning 
the treatment, the pantavalent antimony is very effective. 
Complete curative outcome can be derived in all cases 
in this series. For treating VL, pentavalent antimonial 
compounds are still the first-line antiinfective agents[16]. 
However, owing to increasing resistance to this agent, 
many patients at present require other drugs including 
amphotericin B and pentamidine[16]. Toxic effects of these 
second-line agents have led to development of new drug 
delivery systems, especially for the liposomal amphotericin 
B, which has shown uniform efficacy in clinical trials[15]. 
In summary, the clinical characteristics of the bone 
marrow leishmaniasis in Thai cases are not different from 
the classical cases in the original site. Focusing on the 
treatment, the adopted therapeutic protocol was effective 
and there is no problem of the drug resistance.
  Finally, the author hereby also would like to discuss on 
the importance of leishmaniasis in Thailand relating to the 
present globalization and good traveling system. Of interest, 
almost all indexed cases in this report are the Thai labors 
who had the history of working in the endemic areas[2]. The 
left one case is a fisherman who also had history of long term 
visiting to the endemic area. It is no doubt that the disease 
was carried from those endemic countries to Thailand. The 
new emerging infectious disease can be diagnosed in these 
cases. Luckily, there is no specific vector for leishmanial 
parasite in Thailand hence there is no continuous 
propagation of infection into the community. In addition, 
there has been only 1 new case report on bone marrow 
lesihmaniasis since 1990’s. This might be due to the concern 
of this disease and improvement of disease control system 
in Thailand. However, this does not mean that there is no 
possibility. It is no doubt that the vector might be carried 
into Thailand via airplane in the future and this is the totally 
unwanted situation.
  The present situation of leishmaniasis in Thailand is under 
control[2]. It is only the disease under surveillance among 
the labors who go working at the Middle East. This is due to 
the basic social factor that the Thai labors would like to go 
working in the Middle East where the salary is better than 
Thailand. Each year, thousands of Thai labors emigrate to 
the Middle East. Nevertheless, it should be further noted 
that there is no reported case in tourist. Indeed, the Middle 
East is not the favorable target of the Thai tourists to go 
in the long vacation and this is the reason that there is no 
reported case in the tourist. On the other hand, it should 
be noted that Thailand is also reported as the original site 
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of many infections such as malaria and dengue among the 
Western tourists who go back to their hometown after a visit 
to Thailand[17]. It is no doubt that the present globalization 
makes the disease easily wanders around the world.
  A concern on leishmaniasis among the traveler is therefore 
an important topic to be discussed. It is no doubt that 
leishmaniasis is accepted as an important disease to be 
focused among traveler at present[18-19]. Pavli et al[18] noted 
that “Leishmaniasis should be considered in patients 
presenting with a compatible clinical syndrome and a history 
of travel to an endemic area, even if this occurred several 
months or years ago[18]”. The emergence of leishmanisis 
in other settings, not only Thailand, was also reported. In 
USA and Europe, leishmaniasis becomes a focused travel-
borne disease among the tourists[20] (which is different from 
Thailand that leishmaniasis is a focused disease among 
the labors.) It is no doubt that leishmaniasis becomes the 
disease under surveillance program of the Western[21]. For 
the Southeast Asia, the emergence of leishmaniasis can 
be seen in many countries adding to the Thai case. For 
example, the case in Vietnam is still controversial for its 
origin and it is implies for the possible new zoonosis from 
rural dogs[22]. Hence, the disease control program must be 
designed.
  Focusing on how to control the leishmaniasis in Thailand, 
these recommendations can be set.
  1 The disease control program for any labors going back 
to Thailand from the long period of working in the endemic 
area in the Middle East; 2 The health educations on the 
disease to any workers pursue working as labors in the 
Middle East before their emigration; 3 The promotion of 
the knowledge of this new emerging disease to the general 
practitioner in Thailand who might have to deal with this 
new emerging infection; 4 The concern should also be given 
on the animal leishmaniasis since the emergence of zoonosis 
leishmaniasis is also possible[23] although it has never 
been existed in Thailand; 5 Finally, the note on the effect 
of the climate change on the pattern of vector that might 
result in the coming of new vector is very important[24-25]. 
Entomological surveillance is also important.
  These recommendations can be applied to other settings 
where the problem of imported leishmaniasis can be 
detectable.
  Although Thailand is not an endemic area of leishmaniasis, 
the infection can be detected in Thailand. There are many 
reported cases on the serious form of leishmaniasis, the 
bone marrow leishmaniasis. The Thai cases are all imported 
infection in the labors that went working in the endemic area 
and carried the infection back to their hometown, Thailand. 
The importance of traveling medicine in this case can be 
shown. Due to the present globalization, the migration, into 
and out of a country, is easily and this can be the root cause 
of the emerging of the new infection in the new setting. The 
summarized cases of bone marrow leishmaniasis in Thailand 
can be the good example.
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